香港股市 將在 8 小時 20 分鐘 開市

Concord Healthcare Grp Co Ltd (2453.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
35.200+0.900 (+2.62%)
收市:04:08PM HKT

Concord Healthcare Grp Co Ltd

East Tower, Hanwei Building
Room 26A1-26A5 No. 7 Guanghua Road Chaoyang District
Beijing 100020
China
86 10 5903 6688
https://www.concordmedical.com

版塊Healthcare
行業Medical Care Facilities
全職員工733

高階主管

名稱頭銜支付行使價出生年份
Dr. Jianyu YangExecutive Chairman of the Board1.91M1971
Ms. Xiao FuGM, President & Executive Director1.93M1967
Mr. Liang ChangVP & Executive Director1.01M1981
Mr. Botao ShiSecretary & Executive Director801.93k1975
Ms. Ying ChangChief Financial Officer1983
Mr. Lichen PanJoint Company Secretary
Ms. Wing Nga HoJoint Company Secretary1972
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates in two segments, Hospital Business; and Medical Equipment, Software and Related Services. The company also offers oncology-related services, including sales and installing of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipment; trading of radiotherapy and diagnostic imaging equipment; technology promotion and application solutions; medical treatment and service, and equipment trading activities; and provision of cancer treatment services. The company was incorporated in 2008 and is headquartered in Beijing, China.

公司管治

截至 無 止,Concord Healthcare Grp Co Ltd 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。